Background The “long tail” of the COVID-19 pandemic will be reflected in disabling
symptoms that persist, fluctuate or recur for extended periods for an estimated 20%–30% of …

Background An unknown proportion of people who had an apparently mild COVID-19
infection continue to suffer with persistent symptoms, including chest pain, shortness of …

Long COVID remains a broadly defined syndrome, with estimates of prevalence and
duration varying widely. We use data from rounds 3–5 of the REACT-2 study (n= 508,707; …

Abstract Background Long Covid is an unknown illness which has been shown to affect
sufferers regardless of mild initial COVID-19 or age. There is still a lot unknown about long …

Purpose Long COVID, an illness affecting a subset of individuals after COVID-19, is
distressing, poorly understood, and reduces quality of life. The objective of this sub-study …

Background Long COVID, describing the long-term sequelae after SARS-CoV-2 infection,
remains a poorly defined syndrome. There is uncertainty about its predisposing factors and …

This narrative inquiry aimed to explore a COVID-19 patient's lived experience from
contracting the disease to recovery and understand the implications of this unique patient …

Objectives There is limited qualitative research on patients' experiences with long COVID-
19, and how specific symptoms impact their daily lives. The study aimed to understand …

Importance Infection with COVID-19 has been associated with long-term symptoms, but the
frequency, variety, and severity of these complications are not well understood. Many …

Objective To determine the impact of persistent symptoms after coronavirus disease 2019
(COVID‐19) in an Australian population. Design, setting, participants We conducted a …